CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)
NCT06755619
·
clinicaltrials.gov ↗
RECRUITING
Status
60
Enrollment
NETWORK
Sponsor class
Conditions
Primary Central Nervous System (CNS) Lymphoma
Sponsor
Nordic Lymphoma Group